The Recall Desk
ModerateFDA (Drugs)·D-865-2015·Announced 2015-04-29

Attix Pharmaceuticals Recalls Procaine Penicillin G Due to Unverified Expiry Dates

Attix Pharmaceuticals is recalling Procaine Penicillin G active pharmaceutical ingredient because stability data does not support the printed expiry dates on repackaged lots.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II, which typically corresponds to a moderate severity level involving temporary or medically reversible adverse health consequences, and no specific injuries or illnesses are reported in the source text.

Plain-English summary

Attix Pharmaceuticals is recalling all lots of Procaine Penicillin G active pharmaceutical ingredient that were repackaged and distributed between January 5, 2012, and February 12, 2015. The product is packaged in varying grams or kilograms in bags or drums. The recall is being conducted because the repackaged products lack stability data to support the printed expiry dates.

The affected product was distributed nationwide to compounding pharmacies and research organizations. The recall covers all lots repackaged and distributed during the specified timeframe. No specific illness or injury reports are mentioned in the source text.

Consumers and healthcare facilities should stop using the affected product and contact their supplier or the recalling firm for instructions on return or disposal. This recall is classified as FDA Class II, indicating a reasonable probability that use of the product may cause temporary or medically reversible adverse health consequences.

The recalled product

Product
Procaine Penicillin G active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 470 recalled by Attix Pharmaceuticals under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 470 products in this recall →